All lobbying filings

SIEMENS MEDICAL SOLUTIONS USA, INC

Lobbying for SIEMENS MEDICAL SOLUTIONS USA, INC

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $770,000.00 expenses · posted Jul 17, 2025

Official filing document

Bills named in this filing 5

S 1717
Ensuring Patient Access to Critical Breakthrough Products Act of 2025
S 1399
Health Tech Investment Act
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
HR 4121
Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026
HR 3838
Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fiscal Year 20…

Lobbying activity 9

Health Issues

Issues related to FDA & third-party regulation of AI and Machine Learning-enabled devices, and potential future frameworks for generative AI; Issues related to Artificial Intelligence for medical devices; and Issues related to data privacy and transparency.

Medicare/Medicaid

S. 1717 - Ensuring Patient Access to Critical Breakthrough Products Act of 2025; S. 1399 - Health Tech Investment Act; and H.R. 1 - One Big Beautiful Bill Act - provisions related Medicare and Medicaid. Issues related to Medicare reimbursement rates; and Issues related to reimbursement for AI.

Budget/Appropriations

H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration (FDA) Appropriation Act, FY 2026; and Draft Bill - Labor-HHS-Education Appropriation Act, FY 2026.

Taxation/Internal Revenue Code

H.R. 1 - One Big Beautiful Bill - provisions related to international tax provisions such as the Base Erosion and Anti-Abuse Tax; Foreign-Derived Intangible Income; and Global Intangible Low-Tax Income.

Trade (domestic/foreign)

Issues related to medical supply chains and procurement; and Issues related to international trade

Tariff (miscellaneous tariff bills)

Issues related to tariffs and supply chain resilience.

Defense

H.R. 3838 - National Defense Authorization Act, 2026 - issues related to right to repair.

Medical/Disease Research/Clinical Labs

Issues related to NIH funding; and Issues related to ARPA-H Funding.

Natural Resources

Issues related to critical minerals supply chains and production.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.